Just because a business does not make any money, does not mean that the stock will go down. For example, Sol-Gel Technologies (NASDAQ:SLGL) shareholders have done very well over the last year, with ...
Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...
PreveCeutical Medical (OTCQB:PRVCF) said it granted Endosane Pharmaceuticals an option to license sol-gel technology for the delivery of cannabinoid products on an exclusive basis. The purpose of the ...
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it ...
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), is pleased to announce that it ...
Patented technology for slow release of topical formulations. Potentially the first single-active benzoyl peroxide to be approved as prescription drug. Two late stage candidates. Funded sufficiently ...
Atai Life Sciences has created a startup to develop a nose-to-brain delivery system for the treatment of mental health disorders. The startup, InnarisBio, has secured exclusive rights to a sol-gel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback